Login

Foundation, Novartis

Defining Optimal Immunotherapies for Type 1 Diabetes: Novartis Foundation Symposium

Foundation, Novartis - Defining Optimal Immunotherapies for Type 1 Diabetes: Novartis Foundation Symposium, ebook

197,65€

Ebook, PDF with Adobe DRM
ISBN: 9780470697412
DRM Restrictions

Printing67 pages with an additional page accrued every 11 hours, capped at 67 pages
Copy to clipboard5 excerpts

  • This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).
  • Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.
  • The book integrates information from human and animal studies.
  • The book considers T1D within the broader context of autoimmune disease.
  • The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure.

Keywords: Immunology, Cell & Molecular Biology, Immunology, Cell & Molecular Biology

Author(s)
Editor
 
Publisher
John Wiley and Sons, Inc.
Publication year
2008
Language
en
Edition
1
Series
Novartis Foundation Symposia
Page amount
222 pages
Category
Natural Sciences
Format
Ebook
eISBN (PDF)
9780470697412
Printed ISBN
9780470723258

Similar titles